[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CY1117037T1 - AURISTATIN COGNITIVE PRODUCTS AND USE THEM FOR CANCER, SELF-DIVERSITY OR POLLUTIONAL DISEASE TREATMENT - Google Patents

AURISTATIN COGNITIVE PRODUCTS AND USE THEM FOR CANCER, SELF-DIVERSITY OR POLLUTIONAL DISEASE TREATMENT

Info

Publication number
CY1117037T1
CY1117037T1 CY20151101132T CY151101132T CY1117037T1 CY 1117037 T1 CY1117037 T1 CY 1117037T1 CY 20151101132 T CY20151101132 T CY 20151101132T CY 151101132 T CY151101132 T CY 151101132T CY 1117037 T1 CY1117037 T1 CY 1117037T1
Authority
CY
Cyprus
Prior art keywords
cancer
pollutional
auristatin
cognitive
diversity
Prior art date
Application number
CY20151101132T
Other languages
Greek (el)
Inventor
Peter D Senter
Svetlana Doronina
Brian E Toki
Original Assignee
Seattle Genetics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11165210.3A external-priority patent/EP2357006B1/en
Application filed by Seattle Genetics, Inc. filed Critical Seattle Genetics, Inc.
Publication of CY1117037T1 publication Critical patent/CY1117037T1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Αποκαλύπτονται προϊόντα σύζευξης Φαρμάκου-Συνδετικού Μορίου-Συνδετήρα, στα οποία ένα Φάρμακο συνδέεται προς έναν Συνδετήρα μέσω ενός Συνδετικού Μορίου που βασίζεται σε πεπτίδιο. Σε μία πραγματοποίηση, ο Συνδετήρας είναι ένα Αντίσωμα. Επίσης αποκαλύπτονται Ενώσεις Φαρμάκου-Συνδετικού Μορίου και Ενώσεις Φάρμακα. Αποκαλύπτονται επίσης μέθοδοι για θεραπεία καρκίνου, αυτοάνοσης ασθένειας ή μολυσματώδους ασθένειας χρησιμοποιώντας τις ενώσεις και συνθέσεις της εφεύρεσης.Disclosed are Drug-Ligand-Ligand Conjugates, in which a Drug is bound to a Ligand via a peptide-based Ligand. In one embodiment, the Connector is an Antibody. Also disclosed are Drug-Binding Compounds and Drug Compounds. Methods for treating cancer, autoimmune disease or infectious disease using the compounds and compositions of the invention are also disclosed.

CY20151101132T 2002-07-31 2015-12-10 AURISTATIN COGNITIVE PRODUCTS AND USE THEM FOR CANCER, SELF-DIVERSITY OR POLLUTIONAL DISEASE TREATMENT CY1117037T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40040302A 2002-07-31 2002-07-31
EP11165210.3A EP2357006B1 (en) 2002-07-31 2003-07-31 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease

Publications (1)

Publication Number Publication Date
CY1117037T1 true CY1117037T1 (en) 2017-04-05

Family

ID=58487027

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151101132T CY1117037T1 (en) 2002-07-31 2015-12-10 AURISTATIN COGNITIVE PRODUCTS AND USE THEM FOR CANCER, SELF-DIVERSITY OR POLLUTIONAL DISEASE TREATMENT

Country Status (1)

Country Link
CY (1) CY1117037T1 (en)

Similar Documents

Publication Publication Date Title
CY1111894T1 (en) AURISTATIN COGNITION PRODUCTS AND USE THEM FOR CANCER, SELF-DIVERSITY OR POLYMER DISEASE TREATMENT
CY1125064T1 (en) BETA-GLYCURONIDE DRUG CONJUGATIONS
CY1118369T1 (en) CATALOGS AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
CY1117114T1 (en) HUMANIZED IMMUNOLABLIZED MONOCLONIC ANTIBODIES FOR THE TREATMENT OF TREATMENT IN NEOPLASMAL DISEASE OR IMMUNITY
CY1119353T1 (en) ANTI-CS1 ANTIBODY TREATMENT USE
CY1120135T1 (en) BRUTON TYRUS MOVEMENT SUSPENSIONS
CY1118317T1 (en) ANTIBODIES CONNECTED TO BLYS
NZ754811A (en) Pyrrolobenzodiazepine-antibody conjugates
CY1115076T1 (en) ANTI-PDGFRα ANTIBODY FOR USE IN TREATMENT OF BREAST METHODS OF BONE
ATE472338T1 (en) ANTI-CD70 ANTIBODY DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
ATE395082T1 (en) ANTIBODIES TO CANCER ANTIGEN TMEFF2 AND ITS APPLICATIONS
AR035977A1 (en) IMMUNOCONJUGADOS OF ANTIBODIES CD44 CITOTOXICOS.
NO20071585L (en) New use of peptide compounds for the treatment of bone pain, chemotherapy and nucleoside induced pain
CY1110043T1 (en) 2-AMINOBENZOUL PRODUCTS
CY1124183T1 (en) ANTI-SEZ6 DRUG CONJUGATES AND METHODS OF USE
CY1117037T1 (en) AURISTATIN COGNITIVE PRODUCTS AND USE THEM FOR CANCER, SELF-DIVERSITY OR POLLUTIONAL DISEASE TREATMENT
DE60319240D1 (en) Use of ligands of CD52 antigen for the treatment of solid tumors and bone cancers
DK1708693T3 (en) Pharmaceutical compositions containing platinum complexes with secondary xanthates and therapeutic uses thereof
CY1111320T1 (en) CRIPTO SPECIAL ANTIBODIES
CY1114835T1 (en) COMPLETE HUMAN ANTIBODIES AGAINST HUMAN 4-1B (CD137)